My main research interest is in coupling cognitive neuroscience (including experimental psychology, computational modeling and neuroimaging) and pharmacological challenges in patients as well as in normal volunteers. I’m also interested in better understanding how […]
Laurence Fiette is a veterinary pathologist, who specialized in experimental pathology. She contributes to the evaluation and validation of in vivo models of host-pathogen interactions, immunity or cancer. Within the Human Histopathology & Animal […]
Mucosal tissues are in direct contact with the environment, and form the first barrier against external threats. Intestinal immunity constantly integrates microbial and dietary derived signals, and must dynamically adapt to ensure host fitness. […]
Our team is interested in the development and functions of Natural Killer cells and ILC1s. NK cells have been ‘accidentally’ identified almost 50 years ago based on their ability to spontaneously lyse tumor cells […]
Lucie Peduto obtained her PhD in Tumor Biology at the University of Lausanne/CHUV (Switzerland) and Ecole Pratique des Hautes Etudes in Paris. She joined the lab of Carl Blobel at Sloan-Kettering Institute (New York) […]
Jost studied biochemistry at the University of Hannover and at the Medical School of Hannover (MHH), in Germany. For his Masters thesis and his Ph.D. studies, he joined the Laboratory of Cell Biology at […]
For many years, I have been working in the field of host cell interaction with M. tuberculosis, and in immunology of TB. I am especially interested in the innate immune response against bacterial infection. In particular […]
Innate immunity and Leptospira La leptospirose est une zoonoose réémergente, négligée et de répartition mondiale, causée par des bactéries pathogènes incluant l’espèce Leptospira interrogans. Ces bactéries spiralées et motiles pénètrent leur hôte par la […]
After graduating as an engineer from Ecole Polytechnique, Jean-Pierre Levraud obtained a PhD in Immunology at Université Pierre et Marie Curie (then Paris VI) in 1997, working on anti-tumor T cell immunity under the […]
